Citadel Advisors - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 26 filers reported holding TENAX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$22,000
-50.0%
72,900
+262.5%
0.00%
Q2 2021$44,000
+46.7%
20,111
+26.0%
0.00%
Q1 2021$30,000
-41.2%
15,964
-41.4%
0.00%
Q4 2020$51,000
+183.3%
27,221
+33.8%
0.00%
Q2 2020$18,000
-37.9%
20,351
-15.7%
0.00%
Q3 2019$29,000
+107.1%
24,149
+140.4%
0.00%
Q2 2019$14,0000.0%10,047
-11.5%
0.00%
Q4 2018$14,00011,3480.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 43,164$61,0000.02%
FAS Wealth Partners, Inc. 58,576$83,0000.01%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
VANGUARD GROUP INC 12,200$17,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,018$7,0000.00%
UBS Group AG 72$00.00%
IFP Advisors, Inc 0$00.00%
Advisor Group, Inc. 3,065$4,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders